european medicines agency (ema)

Vitrakvi (larotrectinib) recommended by the CHMP for approval in the EU.

With recent drops in new HIV diagnoses being linked to buying PrEP through online buyers clubs, the addition of PrEP to the WHO's essential medicine list, and the recent approval of generic PrEP in the US - here’s what you need to know.

The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments.